HSV-Induced Systemic Inflammation as an Animal Model for Behçet's Disease and Therapeutic Applications

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
herpes simplex 2 infectiousdiseases
pentoxifylline 1 infectiousdiseasesdrugs
famciclovir 1 infectiousdiseasesdrugs

Graph of close proximity drug and disease terms (within 200 characters).

Note: If this graph is empty, then there are no terms that meet the proximity constraint.


Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
famciclovir 10826 Taraxaci and colchicine can reduce symptoms in 80% of BD mice, much higher than colchicine (30%) or famciclovir (40%) treatment alone. Herba Taraxaci alone or in combination with colchicine can up-regulate frequencies
pentoxifylline 23684 dendritic cells [[98]]. CD206 has elevated frequencies in HSV-1 induced BD mice [[99]]. Colchicine and pentoxifylline are commercial drugs used for BD patients. They can decrease frequencies of CD206 in HSV-1-induced BD
Select Disease Character Offset Disease Term Instance
herpes simplex 961 been used to enable more effective therapeutic applications with increased clinical significance. An herpes simplex virus (HSV) type 1-induced BD mouse model has shown disease characteristics similar to those seen in
herpes simplex 25302 animal models will be significant progress for the BD research field.Figure 1Changes in symptoms of herpes simplex virus (HSV)-induced Behçet’s disease mouse after treatment with SK126.Figure 2IL-6 small interfering

You must be authorized to submit a review.